Agrisera blog

GRC Chloroplast Biotechnology, Ventura

Agrisera compartment marker antibodies

The Gordon Research Conference on Chloroplast Biotechnology took place in Ventura California between Jan 18 and 23. This was the first GRC on this topic. The conference was exciting from beginning to end, with a mix of basic and very applied research presented. Attendees were from across North America and around the world. Agrisera presented a poster describing antibody compartment markers (picture above).
Read more 2015-01-27

24th Western Photosynthesis Conference

Agrisera on WPC2015

From January 8 to 11, Agrisera represented by Dr. Chris Brown from Environmental Proteomics (Canada), attended the 24th Western Photosynthesis Conference (WPC) in Asilomar California. This conference draws some of the top labs in the western US, as well as several from central US and from across the Pacific in Taiwan, Japan, and Korea. This year’s WPC did not disappoint.
Read more 2015-01-27

Agrisera entered Commercial Partnership Targeting the Agri-bio Reagents Market

Agrisera Avacta logo

Agrisera AB has entered into commercial agreement with Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare.  The aim is to develop Affimer based purification systems for proteomics applications. Agrisera has been established for over thirty years and specialises in development and marketing of antibodies and related research tools globally, offering several thousand antibodies for plant and algal cell biology research.

Plant proteomics is a rapidly growing field like human proteomics in which scientists are working to understand the relationships between proteins and diseases to drive a revolution in the way issues such as food security, safety and human health are addressed. In proteomics, samples are often dominated by highly abundant proteins making it difficult to detect the rare proteins that may be the most important in a disease process. Therefore, frequently, samples need to be enriched for non-abundant proteins to facilitate proteomic analysis. This is currently done using antibodies to extract the highly abundant proteins using a bead based affinity column. Affimers are an engineered alternative to antibodies. The market opportunity, whilst difficult to quantitate accurately, is significant. Agrisera AB and Avacta Life Sciences have entered into an agreement to develop Affimer based depletion products with improved performance and economics compared to the current systems. The agreement provides for commercialisation to be carried out by Agrisera under an undisclosed revenue sharing model.

Greger Nordlund, Chief Executive Officer of Agrisera, said: "We are very pleased to enter into this collaboration with Avacta employing their promising Affimer technology. This collaboration is fully in line with Agrisera's strategy to develop and provide novel, effective tools and reagents to the research community."

Dr Alastair Smith, Avacta Group Chief Executive Officer, commented: "Agrisera is a well respected, high quality provider of research tools for plant sciences research and I am delighted that we will be working with them to develop the first Affimer based product for the agri-bio market. "This market, in general, is not as well served as the human life sciences market by the large antibody suppliers, so there is a great opportunity for Avacta to establish Affimers in a growing market where there are many gaps, as well as pushing forward with our plans to address the human life sciences market."
Read more 2015-01-26

Agrisera collaborates with KNOW center in Poland

KNOW center Poznan

Agrisera continues a very fruitful collaboration with the Faculty of Biology at Adam Mickiewicz University in Poznan, Poland. The Faculty recently obtained a status of a KNOW center – Leading National Research Centre, together with the Institute of Bioorganic Chemistry, Polish Academy of Sciences in Poznan. This status, assigned through competition, can only be given to institutions carrying out scientific research at the highest level and providing PhD studies of the highest quality. Both units are well known for their studies on RNA structure, function, and metabolism. Poznan RNA Research Centre will get additional money to support various aspects of RNA research: from basic research on RNA metabolism in bacteria, plants and human, through more applied studies on RNA viruses and the role of RNA in cancer and inherited diseases and their therapies, up to the development of bioinformatics tools allowing advanced structure-function studies. Many new antibodies for proteins involved in RNA metabolism will be produced in a near future. To learn more about the Poznan RNA research Centre visit their KNOW center Poznan.
Read more 2015-01-16
 Agrisera blog


ARTICLE 1-5 5.1  | Show all